HEADER VIRAL PROTEIN/INHIBITOR 16-APR-23 8J3A TITLE CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE Y54C MUTANT IN COMPLEX TITLE 2 WITH PF00835231 COMPND MOL_ID: 1; COMPND 2 MOLECULE: 3C-LIKE PROTEINASE NSP5; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: 3CL-PRO,3CLP,MAIN PROTEASE,MPRO,NON-STRUCTURAL PROTEIN 5, COMPND 5 NSP5,SARS CORONAVIRUS MAIN PROTEINASE; COMPND 6 EC: 3.4.22.69; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_TAXID: 2697049; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS VIRAL PROTEIN-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR X.L.ZHOU,C.LIN,X.F.ZOU,J.ZHANG,J.LI REVDAT 1 17-APR-24 8J3A 0 JRNL AUTH X.L.ZHOU,C.LIN,X.F.ZOU,J.ZHANG,J.LI JRNL TITL CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE Y54C MUTANT IN JRNL TITL 2 COMPLEX WITH PF00835231 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.91 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.12_2829 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.91 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.33 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.338 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 46639 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.202 REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.235 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.867 REMARK 3 FREE R VALUE TEST SET COUNT : 2270 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 37.3300 - 4.8166 0.99 2802 141 0.1553 0.1777 REMARK 3 2 4.8166 - 3.8243 0.99 2800 141 0.1525 0.1684 REMARK 3 3 3.8243 - 3.3412 0.99 2775 142 0.1857 0.2113 REMARK 3 4 3.3412 - 3.0359 0.99 2754 133 0.2243 0.2585 REMARK 3 5 3.0359 - 2.8184 1.00 2769 147 0.2349 0.2797 REMARK 3 6 2.8184 - 2.6522 1.00 2776 131 0.2298 0.2763 REMARK 3 7 2.6522 - 2.5194 1.00 2801 121 0.2328 0.2849 REMARK 3 8 2.5194 - 2.4098 1.00 2775 126 0.2270 0.2671 REMARK 3 9 2.4098 - 2.3170 1.00 2784 142 0.2110 0.3151 REMARK 3 10 2.3170 - 2.2371 1.00 2776 125 0.2271 0.2736 REMARK 3 11 2.2371 - 2.1672 1.00 2775 132 0.2336 0.2752 REMARK 3 12 2.1672 - 2.1052 1.00 2753 121 0.2459 0.2806 REMARK 3 13 2.1052 - 2.0498 1.00 2785 147 0.2481 0.3132 REMARK 3 14 2.0498 - 1.9998 1.00 2745 170 0.2627 0.3305 REMARK 3 15 1.9998 - 1.9543 1.00 2727 173 0.2802 0.2912 REMARK 3 16 1.9543 - 1.9100 1.00 2772 178 0.3243 0.3475 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.253 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.390 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 32.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 40.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 4468 REMARK 3 ANGLE : 0.902 6089 REMARK 3 CHIRALITY : 0.057 702 REMARK 3 PLANARITY : 0.006 786 REMARK 3 DIHEDRAL : 8.877 2575 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8J3A COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 05-JAN-24. REMARK 100 THE DEPOSITION ID IS D_1300036917. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-SEP-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL10U2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97918 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 46688 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.910 REMARK 200 RESOLUTION RANGE LOW (A) : 48.960 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 6.100 REMARK 200 R MERGE (I) : 0.06200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.91 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.02 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.48800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.79 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.36 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M NA2SO4, 20%PEG3350, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 49.96300 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 45 REMARK 465 SER A 46 REMARK 465 GLU A 47 REMARK 465 ASP A 48 REMARK 465 MET A 49 REMARK 465 LEU A 50 REMARK 465 ASN A 51 REMARK 465 PRO A 52 REMARK 465 ASN A 53 REMARK 465 CYS A 54 REMARK 465 GLU A 55 REMARK 465 ASP A 56 REMARK 465 LEU A 57 REMARK 465 LEU A 58 REMARK 465 ILE A 59 REMARK 465 ARG A 60 REMARK 465 LYS A 61 REMARK 465 THR B 45 REMARK 465 SER B 46 REMARK 465 GLU B 47 REMARK 465 ASP B 48 REMARK 465 MET B 49 REMARK 465 LEU B 50 REMARK 465 ASN B 51 REMARK 465 PRO B 52 REMARK 465 ASN B 53 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PHE A 3 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG A 76 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 100 CG CD CE NZ REMARK 470 TYR A 154 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ARG A 222 CG CD NE CZ NH1 NH2 REMARK 470 PHE A 223 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 236 CG CD CE NZ REMARK 470 GLU A 270 CG CD OE1 OE2 REMARK 470 MET A 276 CG SD CE REMARK 470 ASN A 277 CG OD1 ND2 REMARK 470 LEU A 286 CG CD1 CD2 REMARK 470 GLN B 69 CG CD OE1 NE2 REMARK 470 ASN B 72 CG OD1 ND2 REMARK 470 GLN B 74 CG CD OE1 NE2 REMARK 470 ARG B 76 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 90 CG CD CE NZ REMARK 470 LYS B 100 CG CD CE NZ REMARK 470 LYS B 102 CG CD CE NZ REMARK 470 LYS B 137 CG CD CE NZ REMARK 470 TYR B 154 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ASP B 155 CG OD1 OD2 REMARK 470 ARG B 188 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 222 CG CD NE CZ NH1 NH2 REMARK 470 MET B 235 CG SD CE REMARK 470 ASP B 245 CG OD1 OD2 REMARK 470 ARG B 279 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 298 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 33 -127.38 46.66 REMARK 500 ASN A 84 -120.94 50.52 REMARK 500 ASP A 155 -0.64 64.45 REMARK 500 PRO A 184 35.71 -85.80 REMARK 500 ARG A 217 21.32 -141.70 REMARK 500 ASN A 277 -124.27 59.28 REMARK 500 ASP B 33 -112.28 47.83 REMARK 500 HIS B 41 0.88 -63.76 REMARK 500 ASN B 84 -124.75 57.24 REMARK 500 REMARK 500 REMARK: NULL DBREF 8J3A A 3 301 UNP P0DTC1 R1A_SARS2 3266 3564 DBREF 8J3A B 3 301 UNP P0DTC1 R1A_SARS2 3266 3564 SEQADV 8J3A CYS A 54 UNP P0DTC1 TYR 3317 ENGINEERED MUTATION SEQADV 8J3A CYS B 54 UNP P0DTC1 TYR 3317 ENGINEERED MUTATION SEQRES 1 A 299 PHE ARG LYS MET ALA PHE PRO SER GLY LYS VAL GLU GLY SEQRES 2 A 299 CYS MET VAL GLN VAL THR CYS GLY THR THR THR LEU ASN SEQRES 3 A 299 GLY LEU TRP LEU ASP ASP VAL VAL TYR CYS PRO ARG HIS SEQRES 4 A 299 VAL ILE CYS THR SER GLU ASP MET LEU ASN PRO ASN CYS SEQRES 5 A 299 GLU ASP LEU LEU ILE ARG LYS SER ASN HIS ASN PHE LEU SEQRES 6 A 299 VAL GLN ALA GLY ASN VAL GLN LEU ARG VAL ILE GLY HIS SEQRES 7 A 299 SER MET GLN ASN CYS VAL LEU LYS LEU LYS VAL ASP THR SEQRES 8 A 299 ALA ASN PRO LYS THR PRO LYS TYR LYS PHE VAL ARG ILE SEQRES 9 A 299 GLN PRO GLY GLN THR PHE SER VAL LEU ALA CYS TYR ASN SEQRES 10 A 299 GLY SER PRO SER GLY VAL TYR GLN CYS ALA MET ARG PRO SEQRES 11 A 299 ASN PHE THR ILE LYS GLY SER PHE LEU ASN GLY SER CYS SEQRES 12 A 299 GLY SER VAL GLY PHE ASN ILE ASP TYR ASP CYS VAL SER SEQRES 13 A 299 PHE CYS TYR MET HIS HIS MET GLU LEU PRO THR GLY VAL SEQRES 14 A 299 HIS ALA GLY THR ASP LEU GLU GLY ASN PHE TYR GLY PRO SEQRES 15 A 299 PHE VAL ASP ARG GLN THR ALA GLN ALA ALA GLY THR ASP SEQRES 16 A 299 THR THR ILE THR VAL ASN VAL LEU ALA TRP LEU TYR ALA SEQRES 17 A 299 ALA VAL ILE ASN GLY ASP ARG TRP PHE LEU ASN ARG PHE SEQRES 18 A 299 THR THR THR LEU ASN ASP PHE ASN LEU VAL ALA MET LYS SEQRES 19 A 299 TYR ASN TYR GLU PRO LEU THR GLN ASP HIS VAL ASP ILE SEQRES 20 A 299 LEU GLY PRO LEU SER ALA GLN THR GLY ILE ALA VAL LEU SEQRES 21 A 299 ASP MET CYS ALA SER LEU LYS GLU LEU LEU GLN ASN GLY SEQRES 22 A 299 MET ASN GLY ARG THR ILE LEU GLY SER ALA LEU LEU GLU SEQRES 23 A 299 ASP GLU PHE THR PRO PHE ASP VAL VAL ARG GLN CYS SER SEQRES 1 B 299 PHE ARG LYS MET ALA PHE PRO SER GLY LYS VAL GLU GLY SEQRES 2 B 299 CYS MET VAL GLN VAL THR CYS GLY THR THR THR LEU ASN SEQRES 3 B 299 GLY LEU TRP LEU ASP ASP VAL VAL TYR CYS PRO ARG HIS SEQRES 4 B 299 VAL ILE CYS THR SER GLU ASP MET LEU ASN PRO ASN CYS SEQRES 5 B 299 GLU ASP LEU LEU ILE ARG LYS SER ASN HIS ASN PHE LEU SEQRES 6 B 299 VAL GLN ALA GLY ASN VAL GLN LEU ARG VAL ILE GLY HIS SEQRES 7 B 299 SER MET GLN ASN CYS VAL LEU LYS LEU LYS VAL ASP THR SEQRES 8 B 299 ALA ASN PRO LYS THR PRO LYS TYR LYS PHE VAL ARG ILE SEQRES 9 B 299 GLN PRO GLY GLN THR PHE SER VAL LEU ALA CYS TYR ASN SEQRES 10 B 299 GLY SER PRO SER GLY VAL TYR GLN CYS ALA MET ARG PRO SEQRES 11 B 299 ASN PHE THR ILE LYS GLY SER PHE LEU ASN GLY SER CYS SEQRES 12 B 299 GLY SER VAL GLY PHE ASN ILE ASP TYR ASP CYS VAL SER SEQRES 13 B 299 PHE CYS TYR MET HIS HIS MET GLU LEU PRO THR GLY VAL SEQRES 14 B 299 HIS ALA GLY THR ASP LEU GLU GLY ASN PHE TYR GLY PRO SEQRES 15 B 299 PHE VAL ASP ARG GLN THR ALA GLN ALA ALA GLY THR ASP SEQRES 16 B 299 THR THR ILE THR VAL ASN VAL LEU ALA TRP LEU TYR ALA SEQRES 17 B 299 ALA VAL ILE ASN GLY ASP ARG TRP PHE LEU ASN ARG PHE SEQRES 18 B 299 THR THR THR LEU ASN ASP PHE ASN LEU VAL ALA MET LYS SEQRES 19 B 299 TYR ASN TYR GLU PRO LEU THR GLN ASP HIS VAL ASP ILE SEQRES 20 B 299 LEU GLY PRO LEU SER ALA GLN THR GLY ILE ALA VAL LEU SEQRES 21 B 299 ASP MET CYS ALA SER LEU LYS GLU LEU LEU GLN ASN GLY SEQRES 22 B 299 MET ASN GLY ARG THR ILE LEU GLY SER ALA LEU LEU GLU SEQRES 23 B 299 ASP GLU PHE THR PRO PHE ASP VAL VAL ARG GLN CYS SER HET V2M A 401 34 HET V2M B 401 34 HETNAM V2M N-[(2S)-1-({(2S,3S)-3,4-DIHYDROXY-1-[(3S)-2- HETNAM 2 V2M OXOPYRROLIDIN-3-YL]BUTAN-2-YL}AMINO)-4-METHYL-1- HETNAM 3 V2M OXOPENTAN-2-YL]-4-METHOXY-1H-INDOLE-2-CARBOXAMIDE HETSYN V2M N-[(2S)-1-({(2S)-4-HYDROXY-3-OXO-1-[(3S)-2- HETSYN 2 V2M OXOPYRROLIDIN-3-YL]BUTAN-2-YL}AMINO)-4-METHYL-1- HETSYN 3 V2M OXOPENTAN-2-YL]-4-METHOXY-1H-INDOLE-2-CARBOXAMIDE, HETSYN 4 V2M BOUND FORM FORMUL 3 V2M 2(C24 H34 N4 O6) FORMUL 5 HOH *74(H2 O) HELIX 1 AA1 SER A 10 GLY A 15 1 6 HELIX 2 AA2 HIS A 41 CYS A 44 5 4 HELIX 3 AA3 SER A 62 HIS A 64 5 3 HELIX 4 AA4 ILE A 200 ASN A 214 1 15 HELIX 5 AA5 THR A 226 TYR A 237 1 12 HELIX 6 AA6 THR A 243 LEU A 250 1 8 HELIX 7 AA7 LEU A 250 GLY A 258 1 9 HELIX 8 AA8 ALA A 260 GLY A 275 1 16 HELIX 9 AA9 THR A 292 SER A 301 1 10 HELIX 10 AB1 SER B 10 GLY B 15 1 6 HELIX 11 AB2 HIS B 41 ILE B 43 5 3 HELIX 12 AB3 GLU B 55 ARG B 60 1 6 HELIX 13 AB4 SER B 62 PHE B 66 5 5 HELIX 14 AB5 ILE B 200 ASN B 214 1 15 HELIX 15 AB6 THR B 226 TYR B 237 1 12 HELIX 16 AB7 THR B 243 LEU B 250 1 8 HELIX 17 AB8 LEU B 250 GLY B 258 1 9 HELIX 18 AB9 ALA B 260 GLY B 275 1 16 HELIX 19 AC1 THR B 292 SER B 301 1 10 SHEET 1 AA1 7 VAL A 73 LEU A 75 0 SHEET 2 AA1 7 PHE A 66 ALA A 70 -1 N VAL A 68 O LEU A 75 SHEET 3 AA1 7 MET A 17 CYS A 22 -1 N GLN A 19 O GLN A 69 SHEET 4 AA1 7 THR A 25 LEU A 32 -1 O GLY A 29 N VAL A 18 SHEET 5 AA1 7 VAL A 35 PRO A 39 -1 O TYR A 37 N LEU A 30 SHEET 6 AA1 7 VAL A 86 VAL A 91 -1 O LEU A 87 N CYS A 38 SHEET 7 AA1 7 VAL A 77 GLN A 83 -1 N ILE A 78 O LYS A 90 SHEET 1 AA2 5 TYR A 101 PHE A 103 0 SHEET 2 AA2 5 CYS A 156 GLU A 166 1 O PHE A 159 N LYS A 102 SHEET 3 AA2 5 VAL A 148 ASP A 153 -1 N ASN A 151 O SER A 158 SHEET 4 AA2 5 THR A 111 TYR A 118 -1 N SER A 113 O PHE A 150 SHEET 5 AA2 5 SER A 121 ALA A 129 -1 O SER A 123 N ALA A 116 SHEET 1 AA3 3 TYR A 101 PHE A 103 0 SHEET 2 AA3 3 CYS A 156 GLU A 166 1 O PHE A 159 N LYS A 102 SHEET 3 AA3 3 HIS A 172 THR A 175 -1 O ALA A 173 N MET A 165 SHEET 1 AA4 7 VAL B 73 LEU B 75 0 SHEET 2 AA4 7 LEU B 67 ALA B 70 -1 N ALA B 70 O VAL B 73 SHEET 3 AA4 7 MET B 17 CYS B 22 -1 N THR B 21 O LEU B 67 SHEET 4 AA4 7 THR B 25 LEU B 32 -1 O GLY B 29 N VAL B 18 SHEET 5 AA4 7 VAL B 35 PRO B 39 -1 O TYR B 37 N LEU B 30 SHEET 6 AA4 7 VAL B 86 VAL B 91 -1 O LEU B 87 N CYS B 38 SHEET 7 AA4 7 VAL B 77 GLN B 83 -1 N SER B 81 O LYS B 88 SHEET 1 AA5 5 LYS B 100 PHE B 103 0 SHEET 2 AA5 5 CYS B 156 GLU B 166 1 O VAL B 157 N LYS B 100 SHEET 3 AA5 5 VAL B 148 ASP B 153 -1 N ASN B 151 O SER B 158 SHEET 4 AA5 5 THR B 111 TYR B 118 -1 N SER B 113 O PHE B 150 SHEET 5 AA5 5 SER B 121 ALA B 129 -1 O SER B 123 N ALA B 116 SHEET 1 AA6 3 LYS B 100 PHE B 103 0 SHEET 2 AA6 3 CYS B 156 GLU B 166 1 O VAL B 157 N LYS B 100 SHEET 3 AA6 3 HIS B 172 THR B 175 -1 O ALA B 173 N MET B 165 LINK SG CYS A 145 C34 V2M A 401 1555 1555 1.80 LINK SG CYS B 145 C34 V2M B 401 1555 1555 1.82 CRYST1 54.872 99.926 58.712 90.00 106.94 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018224 0.000000 0.005552 0.00000 SCALE2 0.000000 0.010007 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017805 0.00000